The Corticosteroid Early and Extended (CORT-E2) Randomized Controlled Trial
The Corticosteroid Early and Extended (CORT-E2) Randomized Controlled Trial
批准号:
474609
负责人:
Rochwerg Bram N
金额:
$62.16万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-07-01 至 2025-07-01
中文摘要
急性低氧性呼吸衰竭(AHRF)或急性呼吸问题是需要住院治疗的最常见原因之一,或者在最严重的情况下,需要进入重症监护病房(ICU)进行高级氧气支持。AHRF有多重
英文摘要
Acute hypoxemic respiratory failure (AHRF), or acute breathing problems, are one of the most common reasons to require hospital admission, or in the most severe cases, admission to the intensive care unit (ICU) for advanced oxygen support. AHRF has multip
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Corticosteroid Early and Extended (CORT-E2) Randomized Controlled Trial
-
批准号:466232
-
项目类别:Operating Grants
-
资助金额:$248.62万
-
财政年份:2022
-
负责人:Rochwerg Bram N
-
依托单位:
Fluids in Septic Shock (FISSH): a randomized controlled trial.
-
批准号:408305
-
项目类别:Operating Grants
-
资助金额:$83.6万
-
财政年份:2019
-
负责人:Rochwerg Bram N
-
依托单位:
海外基金